Drug
KL0011034 clinical trials
- studies test it
- 5
- open now
- 4
- in phase 3
- 0
- first study started
- 2026
Keep track of what changes. Save the KL0011034 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 2
Hunan Kelun Pharmaceutical Co., Ltd. (3) · The Third Xiangya Hospital of Central South University (2)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses KL0011034 is read from its arms, and is right about nine times in ten.
Testing it · 5
- Safety, Pharmacokinetics, and Pharmacodynamics of Continuous KL0011034 Infusion in Healthy Chinese AdultsNot yet recruitingPhase 1The Third Xiangya Hospital of Central South UniversityNCT07841626Written as KL0011034 Injection
- A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of KL0011034 Injection Administered by Continuous Infusion in Healthy Adult SubjectsNot yet recruitingPhase 1Hunan Kelun Pharmaceutical Co., Ltd.NCT07828470Written as KL0011034 injection
- A Study to Evaluate the Drug-Drug Interaction Between KL0011034 Injection and Alfentanil Hydrochloride Injection in Participants With Moderate-to-Severe Non-Cancer Chronic PainNot yet recruitingPhase 1The Third Xiangya Hospital of Central South UniversityNCT07751094Written as KL0011034 injection
- A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KL0011034 Injection in Healthy VolunteersRecruitingPhase 1Hunan Kelun Pharmaceutical Co., Ltd.NCT07474545Written as KL0011034 injection
- A Study Evaluating the Drug-Drug Interaction Between KL0011034 Injection and Alfentanil Hydrochloride InjectionCompletedPhase 1Hunan Kelun Pharmaceutical Co., Ltd.NCT07710560Written as KL0011034 injection